These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8816840

  • 1. Predicting response to therapy of squamous cell carcinoma of the head and neck (review).
    Wennerberg J.
    Anticancer Res; 1996; 16(4C):2389-96. PubMed ID: 8816840
    [Abstract] [Full Text] [Related]

  • 2. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 3. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J.
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y.
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [Abstract] [Full Text] [Related]

  • 5. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G.
    Anticancer Res; 2000 Apr; 20(2A):997-1004. PubMed ID: 10810387
    [Abstract] [Full Text] [Related]

  • 6. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P, Temam S, Charlotte F, Lacau-St-Guily J.
    Br J Cancer; 2002 Dec 02; 87(12):1390-5. PubMed ID: 12454767
    [Abstract] [Full Text] [Related]

  • 7. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P, Adelstein DJ, Myles J, Secic M.
    Laryngoscope; 2001 Nov 02; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P, Dusek L, Veselý K, Rottenberg J, Kostrica R.
    Neoplasma; 2005 Nov 02; 52(3):199-207. PubMed ID: 15875080
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R, Ciruelos E, Amador ML, Benito A, Sanchez JJ, Ballestin C, Cortes-Funes H.
    Eur J Cancer; 2005 Feb 02; 41(3):453-60. PubMed ID: 15691646
    [Abstract] [Full Text] [Related]

  • 10. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
    Hussein MR, Cullen K.
    Expert Rev Anticancer Ther; 2001 Jun 02; 1(1):116-24. PubMed ID: 12113118
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S, Cvetkovska E, Westin T, Young C.
    Laryngoscope; 2001 Jan 02; 111(1):124-30. PubMed ID: 11192880
    [Abstract] [Full Text] [Related]

  • 12. In vivo cell kinetics in elderly patients affected by squamous cell carcinoma of the head and neck.
    Corvò R, Sanguineti G, Vitale V, Bacigalupo A, Margarino G, Benasso M, Numico GM, Giaretti W.
    Rays; 1997 Jan 02; 22(1 Suppl):69-72. PubMed ID: 9250019
    [Abstract] [Full Text] [Related]

  • 13. The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.
    Björk-Eriksson T, West CM, Cvetskovska E, Svensson M, Karlsson E, Magnusson B, Slevin NJ, Edström S, Mercke C.
    Br J Cancer; 1999 Jul 02; 80(9):1400-4. PubMed ID: 10424742
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.
    Laryngoscope; 2002 Dec 02; 112(12):2129-40. PubMed ID: 12461330
    [Abstract] [Full Text] [Related]

  • 15. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM, Bentzen SM, Daley FM, Dische S, Saunders MI, Richman PI, Wilson GD.
    Clin Cancer Res; 2004 Jun 01; 10(11):3745-54. PubMed ID: 15173081
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 17. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
    Garozzo A, Cutrona D, Palmeri S, Maiolino L, Puzzo L, Allegra E.
    Acta Otorhinolaryngol Ital; 1999 Dec 01; 19(6):342-7. PubMed ID: 10875157
    [Abstract] [Full Text] [Related]

  • 18. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma].
    Wang XL, Qian XL, Zhao QZ, Xu ZG, Tang PZ.
    Ai Zheng; 2003 Nov 01; 22(11):1140-6. PubMed ID: 14613640
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ, Pameijer FA, de Bois J, Heemsbergen W, Balm AJ, Schornagel JH, Rasch CR.
    Head Neck; 2008 Sep 01; 30(9):1216-23. PubMed ID: 18642295
    [Abstract] [Full Text] [Related]

  • 20. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL.
    Clin Cancer Res; 1997 Feb 01; 3(2):185-91. PubMed ID: 9815671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.